This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Recro Gainesville LLC, Alkermes Science One Limited, Recro Technology LLC. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 7 
1 out of 1 
1 out of 1 Years Active: 2015-2019
Title: Innovations of Sharon Hamm: Pioneering Controlled Release Compositions
Introduction
Sharon Hamm, an accomplished inventor based in Atlanta, GA, has made significant strides in the field of pharmaceutical compositions. With a total of four patents to her name, her innovative work focuses on developing controlled release formulations for critical health conditions, particularly those related to cardiovascular disorders.
Latest Patents
Sharon Hamm's latest patents involve controlled release compositions that combine isosorbide dinitrate and hydralazine hydrochloride. This invention aims to enhance the treatment of angina, ischaemic heart disease, arterial hypertension, and various related conditions. The formulations she developed are designed to deliver medication in a pulsed or multi-modal manner, allowing for a more effective therapeutic profile. Importantly, the components can be released from the dosage form through an erodable and diffusion or osmotic-controlled release profile, optimizing patient outcomes.
Career Highlights
Throughout her career, Sharon has worked with notable companies in the pharmaceutical sector, including Recro Gainesville LLC and Alkermes Science One Limited. These experiences have significantly contributed to her understanding and expertise in drug formulation and delivery systems.
Collaborations
Sharon has collaborated with talented professionals such as Gurvinder Singh Rekhi and Richard Sidwell. These partnerships have not only broadened her insights into pharmaceutical innovations but have also facilitated impactful advancements in her research endeavors.
Conclusion
Sharon Hamm's contributions to the realm of controlled release compositions underscore her dedication to improving patient treatment options for cardiovascular diseases. Her innovative patents reflect her commitment to excellence and her significant impact on the pharmaceutical industry. As she continues her work, it will be exciting to see how her future endeavors further enhance therapeutic interventions in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile